English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Monday, April 17, 2023
寿康集团:Fortacin™╱Senstend™中国第三期随机临床试验取得十分优秀的成果
壽康集團:Fortacin™╱Senstend™中國第三期隨機臨床試驗取得十分優秀的成果
Endurance RP: Excellent Positive Results from Phase 3 Randomised Clinical Trial of Fortacin(TM)/Senstend(TM) in China

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575